Intracameral Implants (Requires Preauthorization)
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Nebraska Policy I.219 alerts
Get alerted when Policy I.219 changes without checking for updates manually.
Monitor payer policy activity
Policy governing preauthorization and medical necessity criteria for one-time intracameral drug-eluting implants (bimatoprost/Durysta and travoprost/iDose TR) to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.